Preference of Life-Sustaining Treatment Among Patients With End Stage Renal Disease - Trial NCT05878171
Access comprehensive clinical trial information for NCT05878171 through Pure Global AI's free database. This phase not specified trial is sponsored by National Taiwan University Hospital and is currently Not yet recruiting. The study focuses on End Stage Renal Disease. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
National Taiwan University Hospital
Timeline & Enrollment
N/A
May 31, 2023
Apr 30, 2024
Primary Outcome
Preference for end-of-life life-sustaining treatment for patients with end-stage renal disease,The influencing factors of life-sustaining treatment preference in patients with end-stage renal disease
Summary
Although patients with kidney disease can rely on dialysis to prolong their lives, the
 complexity of the disease, the variability of the course of the disease, and the uncertainty
 of the prognosis often delay the discussion of issues at the end of life, and the
 deterioration of the condition often makes it impossible for the patient to express clearly
 or rationally. Treatment thoughts or preferences. Sufficient time is needed to think and
 discuss issues related to life treatment. Discuss with patients as soon as possible to help
 draw up end-of-life care plans, help patients realize end-of-life care preferences, assist
 family members to make complex treatment decisions, and alleviate medical providers' moral
 distress. Domestic life-sustaining treatment research is mostly signed by DNR for cancer
 patients and retrospective investigation of medical records, and seldom focuses on kidney
 disease patients and life-sustaining treatment survey preferences other than DNR content.
 This study sought to understand patients with kidney disease's preferences for
 life-sustaining care during disease progression, and to understand whether prognostic
 perceptions, symptom distress, dementia, and decision conflict affect patients' preferences.
 Pre-collected convenient sampling is expected to include 200 patients diagnosed with chronic
 kidney disease stage 5 or end-stage renal disease, including patients who have received
 regular dialysis. The survey will be conducted with a single questionnaire. There are five
 questionnaires, including: demographic characteristics, chronic kidney disease prognosis
 cognition And life-support treatment information questionnaire, short-form recall symptom
 assessment scale, loss of memory scale and decision-making conflict scale; after the
 researcher explains, the patient fills in by himself or the researcher fills in after the
 patient answers. It is expected that the results of the study will help clinical
 practitioners to understand the changes in the management of medical care for kidney disease
 patients when the disease worsens and assist in the management of patients' medical care,
 echoing the importance of advancing medical care planning in this population, for the future
 development of kidney disease A reference for care guidelines for debilitated patients,
 thereby improving care quality and satisfaction.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05878171
Non-Device Trial